### ü´Å Pulm/CC: Diagnosis of tracheal stenosis using spirometry

#### ‚úÖ True Statements
1. A **flow-volume loop** showing flattening of both the inspiratory and expiratory limbs suggests a **fixed airway obstruction**, such as tumor or tracheal stenosis.
2. **Flow-volume loops** plot air flow against volume during maximal inspiration and expiration.
3. Flattened inspiratory and expiratory limbs suggest a fixed airway obstruction.
4. **Tracheal stenosis** occurs in up to 10% of patients following tracheostomy.
5. Tracheal stenosis often presents with **exertional dyspnea**.
6. In **asthma**, spirometry demonstrates a decrease in **forced expiratory volume in 1 second (FEV1)** and the **FEV1/forced vital capacity (FVC) ratio**, with improvement in FEV1 and/or FVC after inhaled bronchodilator administration.
7. The flow-volume loop in asthma typically shows a **concave expiratory limb** rather than a flattened limb.
8. **Inducible laryngeal obstruction (ILO)** is a transient inappropriate narrowing of the larynx in response to triggers such as asthma, exercise, and stress.
9. Spirometry in ILO may show flattening of the inspiratory loop of the flow-volume curve, but **laryngoscopy is required** for diagnosis.
10. The flow-volume loop in **neuromuscular weakness** is characterized by a narrow flow-volume plot and a reduction in all lung volumes.

#### üí¨ Extra(s)
1. Flattened inspiratory and expiratory limbs on a flow-volume loop are inconsistent with asthma, ILO, or neuromuscular weakness.
4. Tracheal stenosis after tracheostomy is associated with exertional dyspnea and characteristic flow-volume loop changes.

#### üìö Reference
Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60. PMID: 34949706 doi:10.1183/13993003.01499-2021

#### üè∑Ô∏è Tags
#Pulmonary #Spirometry #FlowVolumeLoop #AirwayObstruction #TrachealStenosis #Ambulatory

#### üÜî Question ID
PMMCQ24042

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP: Pulmonary Medicine, Pulmonary Diagnostic Tests, Pulmonary Function Testing, Pulmonary Function Testing Interpretation

---

### üìò Related Text Derivations

#### ‚úÖ Additional True Statements (from Related Text)
1. Pulmonary function testing interpretation classifies abnormal results as **obstructive**, **restrictive**, or **mixed obstructive/restrictive**, and assesses the severity of impairment.
2. A reduced **FEV1/FVC ratio** is consistent with obstruction.
3. Severity of obstruction is determined according to the measured **FEV1** as a percentage of the predicted value.
4. The American Thoracic Society and European Respiratory Society define a reduced FEV1/FVC ratio as below the **lower limit of normal**, whereas the Global Initiative for Chronic Obstructive Lung Disease defines a reduced ratio as below **0.70** on a postbronchodilator test.
5. The American Thoracic Society and European Respiratory Society 2021 technical standard defines bronchodilator responsiveness as an increase from baseline in FEV1, FVC, or both of at least **10% relative to the predicted value**.
6. Many laboratories still use the former thresholds (12% and 200 mL) for a significant bronchodilator response.
7. Measurement of **lung volumes** may help in assessing obstructive lung disease but is not necessary for diagnosis.
8. Elevation of **total lung capacity (TLC)** and **residual volume** (120% or greater of predicted) generally indicates **hyperinflation and air trapping**.
9. If FEV1 or FVC is reduced and the FEV1/FVC ratio is **0.70 or greater**, then the pattern may be restrictive, but measurement of TLC is needed to confirm restriction.
10. If TLC is less than 80% of predicted (or below the lower limit of normal), a restrictive pattern is present.
11. Some patients have coexisting restrictive and obstructive disorders, such as **combined pulmonary fibrosis and emphysema**.
12. **Obesity** often results in reduced lung volumes (FEV1 and FVC) with a preserved FEV1/FVC ratio and modest reductions in TLC and expiratory reserve volume.
13. **Diffusing capacity of the lung for carbon monoxide (Dlco)** is reduced in conditions with destruction, infiltration, or removal of alveolar-capillary units, or when their function is compromised.
14. Dlco may be increased in conditions that raise pulmonary capillary blood volume, such as pulmonary alveolar hemorrhage, left-to-right shunt, or asthma.
15. The **flow-volume loop** is a graphic representation of maximally forced inspiratory and expiratory flow (Y-axis) against volume (X-axis).
16. The shape of the spirometric flow-volume loop can help differentiate obstructive from restrictive patterns and suggest the anatomic location of airway obstruction.

#### üí¨ Extra(s)
3. Obstructive patterns require both reduced FEV1 and reduced FEV1/FVC ratio.
9. Restrictive patterns require confirmation with TLC measurement.
12. Obesity-related spirometry changes may mimic restrictive patterns but typically show preserved FEV1/FVC ratio.

#### üè∑Ô∏è Related Text Tags
#Pulmonary #PulmonaryFunctionTesting #Spirometry #ObstructiveDisease #RestrictiveDisease #COPD #Asthma #InterstitialLungDisease #Obesity #Ambulatory

---

#### üñºÔ∏è Supplemental Figure(s)
<figure><img src="/mnt/data/Diagnose tracheal stenosis using spirometry.svg" alt="Flow-volume loop showing tracheal stenosis"><figcaption>Figure: Flow-volume loop showing tracheal stenosis.</figcaption></figure>
<figure><img src="/mnt/data/24548fc6-7de3-4fef-b7a0-ed80f8abffc2.png" alt="Characterization of Impairment Severity in Pulmonary Function Tests"><figcaption>Figure: Characterization of Impairment Severity in Pulmonary Function Tests.</figcaption></figure>
<figure><img src="/mnt/data/Classic Flow-Volume Loops on Spirometry.svg" alt="Classic flow-volume loops on spirometry"><figcaption>Figure: Classic Flow-Volume Loops on Spirometry.</figcaption></figure>

#### üîä Supplemental Video(s)
<!-- None -->

#### üóæ Supplemental HTML Table(s)
<table>
  <caption><strong>Characterization of Impairment Severity in Pulmonary Function Tests</strong></caption>
  <thead>
    <tr>
      <th>Test Result (% of Predicted)</th>
      <th>Severity of Impairment</th>
    </tr>
  </thead>
  <tbody>
    <tr><td colspan="2"><strong>FEV<sub>1</sub></strong></td></tr>
    <tr><td>70-79</td><td>Mild</td></tr>
    <tr><td>60-69</td><td>Moderate</td></tr>
    <tr><td>50-59</td><td>Moderately severe</td></tr>
    <tr><td>35-49</td><td>Severe</td></tr>
    <tr><td>&lt;35</td><td>Very severe</td></tr>
    <tr><td colspan="2"><strong>D<sub>LCO</sub></strong></td></tr>
    <tr><td>&lt;LLN but &gt;60</td><td>Mild</td></tr>
    <tr><td>40-60</td><td>Moderate</td></tr>
    <tr><td>&lt;40</td><td>Severe</td></tr>
  </tbody>
</table>

#### ‚úÖ True Statements (from Table: Characterization of Impairment Severity in Pulmonary Function Tests)
1. An FEV1 of 70‚Äì79% of predicted indicates **mild impairment**.
2. An FEV1 of 60‚Äì69% of predicted indicates **moderate impairment**.
3. An FEV1 of 50‚Äì59% of predicted indicates **moderately severe impairment**.
4. An FEV1 of 35‚Äì49% of predicted indicates **severe impairment**.
5. An FEV1 of less than 35% of predicted indicates **very severe impairment**.
6. A Dlco less than the lower limit of normal but greater than 60% of predicted indicates **mild impairment**.
7. A Dlco of 40‚Äì60% of predicted indicates **moderate impairment**.
8. A Dlco less than 40% of predicted indicates **severe impairment**.

#### üí¨ Optional Extra(s)
1. The table provides standardized thresholds for interpreting severity of impairment in pulmonary function testing.